Expressions Correlation of P53,vegf,cox-2 and EGFR in Bladder Cancer and Their Clinical Significance

Guo H

2013-01-01

Abstract:Objective This study was designed to investigate the expressions of p53,VEGF,COX-2 and EGFR in bladder cancer tissues,and to explore the relationship between the expressions and clinicopathological parameters in patients with bladder cancer.Methods The expressions of p53,VEGF,COX-2 and EGFR in 163 cases of bladder cancer were assessed by immunohistochemistry,and their correlations with clinicopathological factors were statistically analyzed.Results The expressions of p53,VEGF and EGFR correlated with the clinical stage(P0.05),but not with the expression of COX-2(P0.05).In addition,the expression intensity of p53 and EGFR increased with higher clinical stage(P0.05).The expression rates and intensity of p53 were associated with pathologic grade(P0.05).The expression intensity of p53 had a positive correlation with the expression intensity of VEGF,COX-2 and EGFR(P0.05),and the expression intensity of COX-2 had a positive correlation with the expression intensity of VEGF and EGFR(P0.05).There was significant difference between single index expression(p53,VEGF,EGFR) and co-expression(p53 combined with VEGF,VEGF combined with EGFR) in bladder transitional cell carcinoma of different clinical stages.Conclusions The abnormal expression of p53,VEGF,COX-2 and EGFR might play a certain role in the course of the genesis and development of bladder transitional cell carcinoma.Combined detection of p53,VEGF and EGFR may help to confirm the clinical stage of bladder transitional cell carcinoma.